These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2508448)

  • 41. Platelet aggregation may not be a prerequisite for collagen-stimulated platelet generation of nitric oxide.
    Smith CC; Stanyer L; Cooper MB; Betteridge DJ
    Biochim Biophys Acta; 1999 Dec; 1473(2-3):286-92. PubMed ID: 10594366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacologic protein kinase Cα inhibition uncouples human platelet-stimulated angiogenesis from collagen-induced aggregation.
    Moncada de la Rosa C; Radziwon-Balicka A; El-Sikhry H; Seubert J; Ruvolo PP; Radomski MW; Jurasz P
    J Pharmacol Exp Ther; 2013 Apr; 345(1):15-24. PubMed ID: 23386249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term smoking impairs platelet-derived nitric oxide release.
    Ichiki K; Ikeda H; Haramaki N; Ueno T; Imaizumi T
    Circulation; 1996 Dec; 94(12):3109-14. PubMed ID: 8989117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.
    de la Cruz JP; Guerrero A; González-Correa JA; Márquez E; Nacle I; Sánchez de la Cuesta F
    Eur J Clin Pharmacol; 2002 Jan; 57(11):775-80. PubMed ID: 11871383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human platelets.
    Sane DC; Bielawska A; Greenberg CS; Hannun YA
    Biochem Biophys Res Commun; 1989 Dec; 165(2):708-14. PubMed ID: 2557018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.
    Radomski MW; Palmer RM; Moncada S
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1482-9. PubMed ID: 2825688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of endothelium-derived relaxing factor on platelet function and hemostasis in vivo.
    Houston DS; Buchanan MR
    Thromb Res; 1994 Apr; 74(1):25-37. PubMed ID: 8029806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets.
    Menys VC; Davies JA
    Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells.
    Hawkins DJ; Meyrick BO; Murray JJ
    Biochim Biophys Acta; 1988 May; 969(3):289-96. PubMed ID: 2897209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Endothelial factors and thrombocyte function].
    Schrör K
    Z Kardiol; 1991; 80 Suppl 5():3-6. PubMed ID: 1776333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
    Bani D; Bigazzi M; Masini E; Bani G; Sacchi TB
    Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of a collagen derived octapeptide on different steps of the platelet/collagen interaction.
    Karniguian A; Legrand YJ; Lefrancier P; Caen JP
    Thromb Res; 1983 Dec; 32(6):593-604. PubMed ID: 6320490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
    Lidbury PS; Antunes E; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Dec; 98(4):1275-80. PubMed ID: 2482103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute vigorous exercise attenuates sensitivity of platelets to nitric oxide.
    Sakita S; Kishi Y; Numano F
    Thromb Res; 1997 Sep; 87(5):461-71. PubMed ID: 9306620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of EDRF and nitric oxide release using [3H]GTP-labeled human platelets.
    Kishi Y; Watanabe R; Ashikaga T; Numano F
    Thromb Res; 1995 Jun; 78(6):483-93. PubMed ID: 15714750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
    Hyslop S; de Nucci G
    Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
    Judge S; Mammen E; Dunbar JC
    J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of nitric oxide-sensitive guanylyl cyclase in human platelets before and after aggregation.
    Kempfert J; Behrends S
    Platelets; 2003; 14(7-8):429-35. PubMed ID: 14713512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.